Clinical Trials · NCT03929679
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice (SURE NETHERLANDS)
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 218
- Start date
- May 2019
- Locations
- 27 sites, Netherlands
- Primary endpoint
- Change in Glycated Haemoglobin A1c (HbA1c)